Teladoc, Inc. (NYSE:TDOC) CEO Jason N. Gorevic sold 20,000 shares of the company’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $33.47, for a total transaction of $669,400.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of Teladoc, Inc. (TDOC) traded up 0.29% during midday trading on Wednesday, hitting $34.80. 488,739 shares of the company traded hands. The stock’s market capitalization is $1.97 billion. The stock has a 50 day moving average of $33.17 and a 200-day moving average of $33.17. Teladoc, Inc. has a 52 week low of $14.00 and a 52 week high of $37.55.

Teladoc (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, August 2nd. The health services provider reported ($0.28) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.26) by ($0.02). Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The business had revenue of $44.60 million for the quarter, compared to analysts’ expectations of $44.39 million. During the same period in the previous year, the firm posted ($0.38) EPS. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. Equities analysts forecast that Teladoc, Inc. will post ($1.44) earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/04/insider-selling-teladoc-inc-tdoc-ceo-sells-20000-shares-of-stock.html.

A number of institutional investors have recently made changes to their positions in TDOC. ETF Managers Group LLC purchased a new stake in Teladoc during the second quarter valued at about $104,000. Bank of Montreal Can lifted its stake in Teladoc by 214.2% during the second quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock worth $123,000 after purchasing an additional 2,397 shares during the last quarter. Pacad Investment Ltd. bought a new stake in Teladoc during the second quarter worth about $135,000. Fred Alger Management Inc. purchased a new position in shares of Teladoc in the 2nd quarter worth about $139,000. Finally, Great West Life Assurance Co. Can purchased a new position in shares of Teladoc in the 1st quarter worth about $105,000.

TDOC has been the subject of several analyst reports. TheStreet cut shares of Teladoc from a “c-” rating to a “d” rating in a research report on Monday, July 3rd. Zacks Investment Research downgraded shares of Teladoc from a “hold” rating to a “sell” rating in a report on Monday, July 17th. Cantor Fitzgerald reiterated a “hold” rating on shares of Teladoc in a research report on Monday, August 28th. Piper Jaffray Companies reiterated a “buy” rating and set a $32.00 price target on shares of Teladoc in a research report on Friday, July 14th. Finally, BidaskClub raised shares of Teladoc from a “sell” rating to a “hold” rating in a research note on Wednesday, September 6th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $38.00.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Insider Buying and Selling by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.